A detailed history of American International Group, Inc. transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, American International Group, Inc. holds 14,232 shares of SCPH stock, worth $59,916. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,232
Previous 14,355 0.86%
Holding current value
$59,916
Previous $90,000 21.11%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$4.86 - $6.39 $597 - $785
-123 Reduced 0.86%
14,232 $71,000
Q4 2023

Feb 13, 2024

SELL
$4.7 - $6.63 $267 - $377
-57 Reduced 0.4%
14,355 $90,000
Q3 2023

Nov 13, 2023

BUY
$7.0 - $9.82 $3,584 - $5,027
512 Added 3.68%
14,412 $102,000
Q2 2023

Aug 04, 2023

BUY
$8.94 - $11.74 $124,266 - $163,186
13,900 New
13,900 $141,000
Q2 2021

Aug 13, 2021

SELL
$5.19 - $7.38 $21,170 - $30,103
-4,079 Closed
0 $0
Q1 2021

May 07, 2021

BUY
$5.65 - $7.66 $62 - $84
11 Added 0.27%
4,079 $27,000
Q4 2020

Feb 12, 2021

SELL
$5.17 - $9.41 $610 - $1,110
-118 Reduced 2.82%
4,068 $22,000
Q3 2020

Nov 04, 2020

BUY
$7.12 - $8.86 $6,400 - $7,965
899 Added 27.35%
4,186 $31,000
Q2 2020

Aug 12, 2020

BUY
$7.01 - $10.96 $23,041 - $36,025
3,287 New
3,287 $24,000
Q2 2019

Aug 13, 2019

SELL
$2.48 - $3.76 $10,758 - $16,310
-4,338 Closed
0 $0
Q1 2019

May 06, 2019

SELL
$2.84 - $4.18 $397 - $585
-140 Reduced 3.13%
4,338 $13,000
Q4 2018

Feb 13, 2019

SELL
$3.76 - $5.61 $131 - $196
-35 Reduced 0.78%
4,478 $17,000
Q3 2018

Nov 09, 2018

BUY
$4.22 - $6.03 $346 - $494
82 Added 1.85%
4,513 $26,000
Q2 2018

Aug 08, 2018

SELL
$5.53 - $15.4 $1,548 - $4,312
-280 Reduced 5.94%
4,431 $25,000
Q1 2018

May 07, 2018

BUY
$11.62 - $17.32 $54,741 - $81,594
4,711 New
4,711 $58,000

Others Institutions Holding SCPH

About scPharmaceuticals Inc.


  • Ticker SCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,402,100
  • Market Cap $115M
  • Description
  • scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...
More about SCPH
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.